According to media reports, US-based Taro Pharmaceutical Industries, subsidiary of Sun Pharmaceutical here, and other group affiliates are investing in a $225-million wind energy project in America.
Meanwhile, in past three trading sessions, the pharma stock has declined 5.3% from Rs 754 on November 18, as compared to 1.4% rise in the S&P BSE Sensex.
On November 20, 2015, Sudhir Valia – person acting in concert - have pledged an additional 2.4 million or 0.10% of his total holding in the company to Kotak Mahindra Investments as security for loan against share, Sun Pharmaceutical said in a statement.
Earlier, on November 16, Sudhir Valia had pledged 4.1 million shares representing 0.17% of his holding in the company to IDBI Trusteeship Services to top up the security cover additional shares were pledged, it added.
No comments:
Post a Comment